Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
NCT ID NCT07718880
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This trial investigates whether drinking fig leaf tea twice a day for 8 weeks, along with a low-glycemic diet, can help protect kidney function in adults with type 2 diabetes and stage 2 chronic kidney disease. Researchers will measure changes in blood sugar, cholesterol, and kidney function markers. The goal is to see if this simple dietary addition can slow the progression of diabetic kidney damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fig leaf tea (Ficus carica L.)
- What this could lead to
- If it works, fig leaf tea could become a simple, natural way to help slow kidney damage in people with diabetes.
- What could go wrong
- This is a small, early-stage trial with only 60 participants. Fig leaf tea is not a proven treatment, and its effects on kidney function are still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Lahore
Lahore, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- Can a nasal spray of insulin shield the aging brain from Post-Surgery confusion?
- Smartphone app could improve blood sugar control in type 2 diabetes
- Personalizing kidney treatment: can biomarkers predict who benefits from finerenone?
- Diabetes drug class may change how the bladder behaves
- Could donating blood help control diabetes and fatty liver?